Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come
Source: SeekingAlpha
2026-06-08 17:27:36 ET
Emergent BioSolutions Inc. ( EBS ) was founded in 1998 and is based in Gaithersburg, MD. It describes itself as ‘a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate, and naturally occurring Public Health Threats.’ Emergent has 11 products, with its business spread across three distinct segments:
- Commercial products, consisting of Narcan 4mg nasal spray and Kloxxado 8mg nasal spray to treat opioid (esp. fentanyl) overdosing;
- Medical counter-measures (MCM) products, consisting of vaccines and treatments for Anthrax and Smallpox, predominantly, alongside also Mpox, Botulism, and Ebola;
- Bioservices offerings.
Read the full article on Seeking Alpha
For further details see:
Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come
Bavarian Nordic A/S
NASDAQ: BVNKF
BVNKF Trading
0.0% G/L:
$27.6924 Last:
405 Volume:
$27.6924 Open:
BVNKF Latest News
July 13, 2026 09:00:00 am
Bavarian Nordic's Chikungunya Vaccine Submitted for Regulatory Approval in Brazil
$2,379,362,265
78,097,834
N/A
N/A
Biotechnology & Life Sciences
Healthcare
DK
Kvistgaard
